Everything tagged "data analytics" across the TickerSpark archives.
NIQ is shifting from post-IPO integration to earnings and cash-flow improvement, with revenue up 8.0%, EBITDA margin expanding, and free cash flow turning positive. Leverage remains elevated, but AI-native growth and a raised 2026 outlook support a measured Buy.
Verisk Analytics is executing well with recurring subscription growth, strong margins, and a growing AI product pipeline. The stock remains a Hold as leverage and a premium valuation limit upside from here.
Equifax delivered strong Q2 growth, expanding margins, and accelerating AI product rollout, but leverage keeps the stock in Buy-not-Strong-Buy territory.
IQVIA is pairing healthcare data scale with accelerating Commercial Solutions growth and a record R&D backlog. The stock looks attractive for investors who can accept leverage in exchange for durable life sciences exposure.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime